Chemerin as a biomarker of inflammatory bowel diseases: a meta-analysis
Abstract Purpose Chemerin, an adipokine involved in immune regulation and inflammation, has been implicated in the pathogenesis of inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC). However, existing studies have reported inconsistent findings regarding its...
| Published in: | BMC Gastroenterology |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-09-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-025-04132-2 |
